CCR4 and synovial sarcoma: In addition, the retinoid X-receptor specific retinoid Bexarotene, which is known to be beneficial to the resolution of cutaneous disease of SS patients, has been shown to induce apoptosis of malignant T cells in SS and also to reduce CCR4 expression with an associated decrease in chemotaxis to CCL17 [142].